WIN 2017 Presentations

WIN 2017 presentations

To view presentations in PDF format, click on the lecture title. Note that not all speakers have given their consent for release of their presentation.

Monday, June 26, 2017

WIN 2017 Keynote Opening Lecture
K1 Genomic-driven Clinical Studies in Breast Cancer
José Baselga, Memorial Sloan Kettering Cancer Center, USA
Download PDF

PLENARY SESSION 1: Innovation In Clinical Trial Design

O1.3 Bayesian Adaptive Designs for Precision Medicine: Promise, Progress and Challenge
J. Jack Lee, University of Texas MD Anderson Cancer Center, USA
Download PDF

O1.4 Redesigning Clinical Trials in the Era of Precision Medicine: What the Science Demands
Razelle Kurzrock, University of California, San Diego Moores Cancer Center, USA
Download PDF

PLENARY SESSION 2: New avenues for target discovery

O2.2 Chromatin dynamics – epigenetic parameters and cellular fate
Geneviève Almouzni, Institut Curie, France
Download PDF

PLENARY SESSION 3: Immunological approach to personalized medicine

O3.1 New biomarkers for response to immunotherapy
Antoni Ribas, University of California Los Angeles, USA
Download PDF

O3.3 The Complex Challenges of Stratifying Patients for Immunotherapy
Steve Anderson, Covance, USA
Download PDF

O3.5 Patient-specific peptide vaccines
Hans-Georg Rammensee, University of Tübingen, Germany
Download PDF

PLENARY SESSION 5: Predict what and how?

O5.3 Augmented Intelligence in the clinical set of Precision Oncology – A IBM Watson perspective
Vanessa V. Michelini, IBM Watson Health, USA
Download PDF

PLENARY SESSION 6: Using new knowledge in clinical trials

O6.4 The INFORM program – personalizing pediatric oncology on a population-based level in Germany
Stefan Pfister, DKFZ, Germany
Download PDF


P8.3 Antitumor activity of RET inhibitor vandetanib with mTOR inhibitor everolimus in patients with Non-small cell Lung Cancer with RET fusion
Vivek Subbiah
Download PDF

Tuesday, June 27, 2017

PLENARY SESSION 4: Next great steps in cancer therapy

O4.1 Novel models to personalize cancer therapeutics
Olli Kallioniemi, Science for Life Laboratory, Karolinska Institutet, Stockholm & Institute for Molecular Medicine Finland (FIMM), Sweden/Finland
Download PDF

O4.3 Genomic analysis of childhood tumors; biological and therapeutic implications
Peter Lichter, DKFZ, Germany
Download PDF

PLENARY SESSION 5: Predict: what and how?

O5.1 Biomarker Research in Breast Cancer: A Journey into the Desert
Martine J. Piccart-Gebhart, Institute Jules Bordet, Belgium
Download PDF

O5.4 Combining immune-based therapies with TKIs in melanomas
Caroline Robert, Gustave Roussy, France
Download PDF

PLENARY SESSION 6: Using new knowledge in clinical trials

O6.2 Incorporating Liquid Biopsies into Clinical Trials to Select and Monitor Participants
Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, USA
Download PDF

O6.3 Molecular medicine in lung cancer
Reinhard Büttner, University Hospital of Cologne, Germany
Download PDF

O6.5 Genomic Predictors of Treatment Response in Prostate Cancer: A New Era
Robert G. Bristow, Princess Margaret Cancer Centre, Canada
Download PDF